GENENTECH, INC for GENENTECH INC

Trade (domestic/foreign) TRD

Issues relating to U.S. trade policy and TransPacific Partnership.

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Copyright/Patent/Trademark CPT

Intellectual Property and Process Patent Issues. General IP Issues; Patent Litigation Reform; Transpacific Partnership Agreement.

Contacted: SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Issues related to several tax issues and tax reform. Issues relating to corporate tax reform including taxation of foreign-owned US corporations. Issues relating to proposed regulations under Section 385 of the Internal Revenue Code.

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; U.S. Trade Representative (USTR); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

S 3040/HR5926, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017. H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. Appropriations for Biosecurity Preparedness; HCR/CDC/HHS - Replenishment of Influenza Antiviral Stockpile.

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 5926 (114th), S. 2956 (114th), H.R. 5054 (114th)

Health Issues HCR

H.R. 34 21st Century Cures Act. Innovation for Healthier Americans -- Senate HELP Committee. Implementation issues related to Pharmaceutical Quality Quality, Security & Accountability Act (PL 113-54). Issues related to the 340B Drug Discount Program. Drug pricing issues. White House Cancer Moonshot & Precision Medicine initiatives. Part B Drug payment issues, CMMI Part B Payment model. Issues related to the implementation of the follow-on biologies provisions in P.L. 11-1148 "PPACA". S.2912, Trickett Wendler Right to Try Act of 2016. Pandemic Preparedness and CDC strategic national stockpile H.R.5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 34 (114th), H.R. 5122 (114th), S. 2912 (114th)

Medicare/Medicaid MMM

Issues relating to CMMI proposed CMMI Part B demo (81 FR 13229) 340B drug discount program. H.R. 34 21st Century Cures Act. Implementation of Medicare Pharmaceutical coverage and reimbursement. Follow-on biologies and Medicare Physician Fee schedule rule to blend ASP for biosimilars. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Contacted: Executive Office of the President (EOP); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 34 (114th), H.R. 5122 (114th)